OraSure Technologies Inc (OSUR)

20.86
0.39 1.91
NASDAQ : Health Care
Prev Close 20.47
Open 20.55
Day Low/High 20.49 / 21.14
52 Wk Low/High 4.39 / 7.99
Volume 689.61K
Avg Volume 878.10K
Exchange NASDAQ
Shares Outstanding 59.46M
Market Cap 1.22B
EPS 0.30
P/E Ratio 37.22
Div & Yield N.A. (N.A)

Latest News

September 15th Options Now Available For OraSure Technologies (OSUR)

September 15th Options Now Available For OraSure Technologies (OSUR)

Investors in OraSure Technologies Inc. saw new options begin trading today, for the September 15th expiration.

OraQuick® HIV Self-Test Selected For Next Phase Of STAR Project For HIV Self-Testing In Africa

OraQuick® HIV Self-Test Selected For Next Phase Of STAR Project For HIV Self-Testing In Africa

~Phase II of STAR Project Expected to Deploy 4 Million Additional HIV Self-Tests~

OraSure Technologies Receives World Health Organization Prequalification Of OraQuick® HIV Self-Test

OraSure Technologies Receives World Health Organization Prequalification Of OraQuick® HIV Self-Test

WHO Prequalification will enable procurement of OraQuick® HIV Self-Test with monies from global public health funding sources

OraSure Technologies Earnings Conference Call Invitation

OraSure Technologies Earnings Conference Call Invitation

2017 Second Quarter Earnings Conference Call Wednesday, August 2, 2017, 5:00 p.m. ET

OraSure Technologies To Drive Accelerated Adoption Of OraQuick® HIV Self-Test

OraSure Technologies enters agreement with Bill & Melinda Gates Foundation to reduce price of rapid, point-of-care HIV self-test in 50 developing countries

OraSure Technologies Reaches Analyst Target Price

In recent trading, shares of OraSure Technologies Inc. have crossed above the average analyst 12-month target price of $14.88, changing hands for $15.12/share.

First Week of June 16th Options Trading For OraSure Technologies (OSUR)

Investors in OraSure Technologies Inc. saw new options become available this week, for the June 16th expiration.

OraSure Technologies Earnings Conference Call Invitation

2017 First Quarter Earnings Conference Call Wednesday, May 3, 2017, 5:00 p.m. ET

First Week Of OSUR May 19th Options Trading

Investors in OraSure Technologies Inc. saw new options become available this week, for the May 19th expiration.

OraSure Technologies Reaches Analyst Target Price

In recent trading, shares of OraSure Technologies Inc. have crossed above the average analyst 12-month target price of $11.42, changing hands for $11.83/share.

Exiting Position With Sizable Gain

We'll sell our remaining shares of OraSure on strength off the company's better-than expected earnings.

CalAtlantic and OraSure to Report After the Close

Both companies have exceeded profit expectations in recent quarters.

Stocks Under $10 Weekly Summary

We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.

Stocks Under $10 Weekly Summary

We used a price decline to add to our position in TherapeuticsMD this week.

Stocks Under $10 Weekly Summary

We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.

Stocks Under $10 Weekly Summary

We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.

OraSure Technologies Earnings Conference Call Invitation

OraSure Technologies Earnings Conference Call Invitation

2016 Fourth Quarter Earnings Conference Call Wednesday, February 8, 2017, 5:00 p.m. ET